⌘K

CARM

NASDAQ

Carisma Therapeutics Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2014

News25/Ratings8

News · 26 weeks260%

2025-10-262026-04-19

Mix090d

No activity.

Latest news

25 items

115dSEC
SEC Form 15-12G filed by Carisma Therapeutics Inc.
15-12G - Carisma Therapeutics Inc. (0001485003) (Filer)
128dSEC
SEC Form EFFECT filed by Carisma Therapeutics Inc.
EFFECT - Carisma Therapeutics Inc. (0001485003) (Filer)
128dSEC
SEC Form EFFECT filed by Carisma Therapeutics Inc.
EFFECT - Carisma Therapeutics Inc. (0001485003) (Filer)
128dSEC
SEC Form EFFECT filed by Carisma Therapeutics Inc.
EFFECT - Carisma Therapeutics Inc. (0001485003) (Filer)
128dSEC
SEC Form EFFECT filed by Carisma Therapeutics Inc.
EFFECT - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form S-8 POS filed by Carisma Therapeutics Inc.
S-8 POS - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form POS AM filed by Carisma Therapeutics Inc.
POS AM - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form POS AM filed by Carisma Therapeutics Inc.
POS AM - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form POS AM filed by Carisma Therapeutics Inc.
POS AM - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form POS AM filed by Carisma Therapeutics Inc.
POS AM - Carisma Therapeutics Inc. (0001485003) (Filer)
129dSEC
SEC Form 25 filed by Carisma Therapeutics Inc.
25 - Carisma Therapeutics Inc. (0001485003) (Filer)
139dSEC
Carisma Therapeutics Inc. filed SEC Form 8-K: Leadership Update
8-K - Carisma Therapeutics Inc. (0001485003) (Filer)
139dPR
Carisma Announces Delisting from Nasdaq and SEC Deregistration
PHILADELPHIA, Dec. 5, 2025 /PRNewswire/ -- Carisma Therapeutics Inc. (OTCID: CARM) (the "Company") today announced that its Board of Directors (the "Board") has approved and the Company intends to proceed with the voluntary delisting of its common stock from The Nasdaq Stock Market LLC ("Nasdaq") and the deregistration of its common stock in order to suspend and ultimately terminate the Company's reporting obligations under the Securities and Exchange Act of 1934, as amended (the "Exchange Act"). As previously reported, as a result of the Company's previously disclosed noncomp